相关实验视频

Updated: Jun 23, 2025

Treatment Protocol for Rotator Cuff Calcific Tendinitis Using a Single-Crystal Piezoelectric Focused Shock Wave Source

Treatment Protocol for Rotator Cuff Calcific Tendinitis Using a Single-Crystal Piezoelectric Focused Shock Wave Source

Published on: December 23, 2022

降脂药物和旋转袖子综合征之间的因果关系:一种药物向的孟德尔随机化研究

Meng-Meng Liu¹, Xiang Chen², Chuan-Wen Yu³

¹School of Physical Education and Health, Guangxi Medical University, Nanning, China.

Frontiers in genetics

|June 21, 2024

概括

这项研究发现,高胆固醇和旋转手套综合征之间没有因果关系. 然而,抑制HMG-CoA还原酶 (HMGCR) 可能会降低旋转部疾病的风险,这表明HMGCR是潜在的治疗标.

科学领域:

遗传学和流行病学
生物化学生物化学

背景情况:

以前的研究表明,脂质失调是旋转手套综合征 (RCS) 的危险因素,但研究结果没有确定性.
门德尔随机化 (MR) 提供了一种强大的方法,通过利用遗传变异推断因果关系,克服传统观测研究的局限性.

研究的目的:

通过使用MR来研究超脂血症和RCS之间的因果关系.
评估降脂药物在治疗RCS中的疗效.
确定HMG-CoA减少酶 (HMGCR) 作为RCS的潜在治疗点.

主要方法:

两个样本的MR分析使用来自英国生物银行和GLGC的脂质特征 (LDL-C,TG,TC) 的遗传数据,以及来自FinnGen.的RCS数据进行.
对RCS的10种药物标进行了药物标MR分析,对重要标进行了使用SMR和同居化进行进一步的调查.
调解分析探讨了BMI在HMGCR-RCS关系中的作用.

主要成果:

在LDL-C,TG或TC和RCS风险之间没有发现因果关系.
抑制HMGCR显示出与降低RCS风险的显著关联 (OR = 0.68).
肌肉组织中增强的HMGCR表达与降低RCS风险有关 (OR = 0.88),BMI调解了这一效应的22.97%.

结论:

这项研究驳斥了失脂症 (LDL-C,TG,TC) 作为旋转手套综合征的直接危险因素.
HMG-CoA减少酶 (HMGCR) 成为预防和治疗RCS的有希望的药物标.
对于RCS而言,他类药物的保护作用可能不仅仅归因于其降脂能力.

关键词:

这就是LDL-C.在TCT上,TCT就是TCT.在TG,TG,TG,TG.药物目标是药物目标.门德尔的随机化是门德尔的随机化旋转手套综合征是指旋转手套综合征.污点污点污点污点

更多相关视频

Measuring 3D In-vivo Shoulder Kinematics using Biplanar Videoradiography

Measuring 3D In-vivo Shoulder Kinematics using Biplanar Videoradiography

Published on: March 12, 2021

Development of a Rabbit Chronic-Like Rotator Cuff Injury Model for Study of Fibrosis and Muscular Fatty Degeneration

Development of a Rabbit Chronic-Like Rotator Cuff Injury Model for Study of Fibrosis and Muscular Fatty Degeneration

Published on: March 31, 2023

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...